Is the Placenta Actually a "Life Bank"? Unveiling the Billion-dollar Import Agency Market

Have you ever wondered that the tissue seemingly regarded as medical waste, the placenta, could become the "soft gold" in the international market? In recent years, with the vigorous development of biotechnology and the aesthetic medicine industry, the import agency of placenta has quietly emerged, forming a segmented market worth billions of dollars. This article will take you to uncover the mystery of this industry and explore its underlying business logic and compliant path.

The placenta is rich in stem cells, growth factors, and various active substances, and has unique value in the fields of regenerative medicine and anti-aging. Mr. Zhang, an expert engaged in biotechnology research, revealed: "The extract of placenta after special treatment shows amazing effects in wound repair and skin regeneration."

The current main demand for high-quality placenta raw materials in the international market comes from:

• Aesthetic medicine industry: Used for high-end anti-aging products
• Biopharmaceutical industry: As a cell culture substrate
• Research institutions: Used for regenerative medicine research

Those engaged in placenta import agency need to cross three thresholds:

• Qualification Certification: Need to obtain a medical device business license and an import approval for special biological products
• Source Audit: Ensure that the donor health screening meets WHO standards
• Cold Chain Logistics: Maintain an environment of -196℃ liquid nitrogen storage throughout the process

Ms. Li has been an agent of the placenta products of Zhongshitong for three years, and she shared: "The most crucial thing is a traceable quality system, and double verification is required for each link from collection to transportation."

The biggest challenges faced by this industry are ethical disputes and regulatory risks. It is recommended that practitioners:

• Strictly follow the human tissue management regulations
• Establish a complete chain of informed consent documents
• Regularly accept flight inspections by drug regulatory departments

It is worth noting that there are great differences in the classification standards of placenta products among different countries. The European Union classifies it as an advanced therapy drug, while some Asian countries classify it as a raw material for health food.

With the development of organoid technology, placenta-derived products may experience explosive growth. However, for the industry to achieve sustainable development, a unified ethical code and quality standards must be established.

Have you ever considered entering this special field? Or do you have unique insights into the application of placenta products? You are welcome to share your views in the comment area. For readers who want to have a deeper understanding of the compliant process, you can send a private message to obtain an abstract of the white paper for the import of special biological products.